Precipio Depreciation & Amortization 2011-2026 | PRPO

Annual Depreciation & Amortization Precipio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
1.24 M	1.2 M	1.22 M	1.22 M	1.13 M	1.09 M	1.12 M	1.26 M	743 K	112 K	489 K	569 K	2.75 M	2.28 M	2.1 M	708 K	852 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.75 M	112 K	1.18 M

Quarterly Depreciation & Amortization Precipio

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
281 K	-	-	324 K	-	-	-	304 K	-	-	-	310 K	-	910 K	604 K	302 K	-	835 K	549 K	268 K	-	829 K	564 K	281 K	-	838 K	560 K	277 K	-	972 K	680 K	352 K	-	395 K	48 K	24 K	-	99 K	55 K	83 K	-	343 K	558 K	41 K	-	589 K	488 K	493 K	-	671 K	687 K	744 K	-	495 K	532 K	513 K	-	481 K	499 K	494 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
972 K	24 K	459 K

Depreciation & Amortization of other stocks in the Diagnostics research industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Castle Biosciences CSTL	40.8 M	$ 20.54	2.55 %	$ 595 M	USA
Fulgent Genetics FLGT	24.9 M	$ 17.38	5.91 %	$ 525 M	USA
Guardant Health GH	39.7 M	$ 118.01	2.64 %	$ 14.8 B	USA
Agilent Technologies A	321 M	$ 114.79	0.93 %	$ 34.9 B	USA
ICON Public Limited Company ICLR	488 M	$ 116.57	1.29 %	$ 9.62 B	Irlanda
Illumina ILMN	354 M	$ 144.83	2.05 %	$ 23 B	USA
Celcuity CELC	167 K	$ 142.53	1.56 %	$ 6.66 B	USA
Co-Diagnostics CODX	1.11 M	$ 3.71	55.23 %	$ 4.94 M	USA
Akumin AKU	98.2 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	112 K	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	1.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	1.66 M	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	15 M	$ 21.57	1.99 %	$ 1.15 B	USA
Chembio Diagnostics CEMI	2.55 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	161 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	587 K	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	70.1 M	$ 94.47	-1.69 %	$ 6.38 B	USA
Interpace Biosciences IDXG	425 K	$ 1.8	-	$ 7.96 M	USA
Medpace Holdings MEDP	27.2 M	$ 430.1	1.95 %	$ 12.4 B	USA
Mettler-Toledo International MTD	51.1 M	$ 1 090.45	0.72 %	$ 22.5 B	Schweiz
Global Cord Blood Corporation CO	43.3 M	-	-	$ 399 M	China
DermTech DMTK	200 K	-	-11.32 %	$ 2.94 M	USA
Personalis PSNL	10 M	$ 8.25	3.77 %	$ 736 M	USA
Charles River Laboratories International CRL	403 M	$ 158.86	1.77 %	$ 7.87 B	USA
Enzo Biochem ENZ	1.27 M	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	36.1 M	$ 9.11	2.36 %	$ 1.17 B	USA
Exact Sciences Corporation EXAS	125 M	-	-	$ 19.8 B	USA
National Research Corporation NRC	7.62 M	$ 19.04	-1.14 %	$ 426 M	USA
Natera NTRA	16.7 M	$ 203.69	-0.6 %	$ 20 B	USA
Myriad Genetics MYGN	53.7 M	$ 3.91	2.62 %	$ 362 M	USA
Heska Corporation HSKA	14 M	-	-	$ 1.31 B	USA
Koninklijke Philips N.V. PHG	1.12 B	$ 27.15	1.53 %	$ 25.7 B	Niderland
Twist Bioscience Corporation TWST	24.9 M	$ 58.84	9.64 %	$ 3.52 B	USA
Senseonics Holdings SENS	1.51 M	$ 6.16	7.88 %	$ 257 M	USA
QIAGEN N.V. QGEN	194 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	2.02 M	-	-	$ 2.69 B	USA
Biomerica BMRA	87 K	$ 2.44	3.83 %	$ 5.6 M	USA
Laboratory Corporation of America Holdings LH	681 M	$ 255.75	-0.65 %	$ 21.3 B	USA
Waters Corporation WAT	88.1 M	$ 340.99	-0.1 %	$ 20.3 B	USA
Thermo Fisher Scientific TMO	1.05 B	$ 449.37	-0.54 %	$ 169 B	USA
Motus GI Holdings MOTS	451 K	-	-34.28 %	$ 263 K	Israel
Exagen XGN	2.1 M	$ 4.27	11.49 %	$ 92.1 M	USA
Neogen Corporation NEOG	119 M	$ 8.86	0.34 %	$ 1.92 B	USA